(SLNO) –
-
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Form 4 SOLENO THERAPEUTICS INC For: Apr 01 Filed by: Yen Kristen
-
Form 4 SOLENO THERAPEUTICS INC For: Apr 01 Filed by: Mackaness James H
-
Form 4 SOLENO THERAPEUTICS INC For: Apr 01 Filed by: Hirano Patricia C
-
Form 4 SOLENO THERAPEUTICS INC For: Apr 01 Filed by: Anish Bhatnagar
-
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Form 8-K SOLENO THERAPEUTICS INC For: Mar 06
-
Form 10-K SOLENO THERAPEUTICS INC For: Dec 31
-
Soleno Therapeutics, Inc. (SLNO) Misses Q4 EPS by 6c
-
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Soleno Therapeutics Inc. (SLNO) PT Raised to $65 at Oppenheimer
-
Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
-
Form SC 13G/A SOLENO THERAPEUTICS INC Filed by: Nantahala Capital Management, LLC
-
Form SC 13G/A SOLENO THERAPEUTICS INC Filed by: COMMODORE CAPITAL LP
-
Form SC 13G/A SOLENO THERAPEUTICS INC Filed by: JANUS HENDERSON GROUP PLC
-
Form SC 13G/A SOLENO THERAPEUTICS INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Piper Sandler Starts Soleno Therapeutics Inc. (SLNO) at Overweight, 'Don't Miss the SLNO Boat Ahead of Approval'
-
Soleno Therapeutics to Present at Upcoming February Investor Conferences
-
Form S-8 SOLENO THERAPEUTICS INC
-
Form 8-K SOLENO THERAPEUTICS INC For: Jan 24
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 25 Filed by: Yen Kristen
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 25 Filed by: Hirano Patricia C
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 25 Filed by: Anish Bhatnagar
-
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Soleno Therapeutics (SLNO) Announces Leadership Appointments
-
Soleno Therapeutics Strengthens Leadership Team with Key Appointments
-
Stifel Starts Soleno Therapeutics Inc. (SLNO) at Buy
-
Form S-8 SOLENO THERAPEUTICS INC
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 08 Filed by: MARIO ERNEST
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 04 Filed by: Yen Kristen
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 04 Filed by: Mackaness James H
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 04 Filed by: Hirano Patricia C
-
Form 4 SOLENO THERAPEUTICS INC For: Jan 04 Filed by: Anish Bhatnagar
-
Form 8-K SOLENO THERAPEUTICS INC For: Jan 04
-
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Soleno Therapeutics (SLNO) Files Mixed Shelf
-
Form S-3ASR SOLENO THERAPEUTICS INC
-
Soleno Therapeutics Inc. (SLNO) PT Raised to $47 at Oppenheimer
-
Soleno Therapeutics Inc. (SLNO) PT Raised to $44 at Guggenheim
-
Form 4 SOLENO THERAPEUTICS INC For: Dec 13 Filed by: Hirano Patricia C
-
Form 4 SOLENO THERAPEUTICS INC For: Dec 12 Filed by: Yen Kristen
-
Form 144 SOLENO THERAPEUTICS INC Filed by: Hirano Patricia C
-
Form 4 SOLENO THERAPEUTICS INC For: Dec 11 Filed by: Mackaness James H
-
Form 4 SOLENO THERAPEUTICS INC For: Dec 11 Filed by: Anish Bhatnagar
-
Form 4 SOLENO THERAPEUTICS INC For: Oct 20 Filed by: Anish Bhatnagar
-
Form 4 SOLENO THERAPEUTICS INC For: Oct 02 Filed by: Mackaness James H
-
Form 144 SOLENO THERAPEUTICS INC Filed by: Hirano Patricia C
-
Form 144 SOLENO THERAPEUTICS INC Filed by: Yen Kristen
-
Form 144 SOLENO THERAPEUTICS INC Filed by: Yen Kristen
-
Form 144 SOLENO THERAPEUTICS INC Filed by: Mackaness James H
Back to SLNO Stock Lookup